Global Pulmonary Function Testing Systems Market Growth 2025-2031

Publication ID:

LPI03256023

Publication Date:

March 26, 2025

Pages:

111

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Pulmonary Function Testing Systems market size is predicted to grow from US$ 440 million in 2025 to US$ 568 million in 2031; it is expected to grow at a CAGR of 4.4% from 2025 to 2031.
Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.
The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.
Global Pulmonary Function Testing Systems main players are CareFusion(BD), Schiller, MGC Diagnostics, M&B, etc. Global top five manufacturers hold a share about 50%. Europe is the largest market, with a share about 30.
The 鈥淧ulmonary Function Testing Systems Industry Forecast鈥� looks at past sales and reviews total world Pulmonary Function Testing Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Pulmonary Function Testing Systems sales for 2025 through 2031. With Pulmonary Function Testing Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pulmonary Function Testing Systems industry.
This Insight Report provides a comprehensive analysis of the global Pulmonary Function Testing Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pulmonary Function Testing Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pulmonary Function Testing Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pulmonary Function Testing Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pulmonary Function Testing Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Function Testing Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Portable PFT Systems
Complete PFT Systems
Segmentation by Application:
Hospitals
Physical Examination Center
Physician Groups
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
CareFusion(BD)
Schiller
CHEST
COSMED
nSpire Health
NDD
MGC Diagnostics
Minato
Ganshorn
AESRI
Morgan Scientific
M&B
Sikeda
RSDQ
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pulmonary Function Testing Systems market?
What factors are driving Pulmonary Function Testing Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pulmonary Function Testing Systems market opportunities vary by end market size?
How does Pulmonary Function Testing Systems break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pulmonary Function Testing Systems Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pulmonary Function Testing Systems by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pulmonary Function Testing Systems by Country/Region, 2020, 2024 & 2031
2.2 Pulmonary Function Testing Systems Segment by Type
2.2.1 Portable PFT Systems
2.2.2 Complete PFT Systems
2.3 Pulmonary Function Testing Systems Sales by Type
2.3.1 Global Pulmonary Function Testing Systems Sales Market Share by Type (2020-2025)
2.3.2 Global Pulmonary Function Testing Systems Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pulmonary Function Testing Systems Sale Price by Type (2020-2025)
2.4 Pulmonary Function Testing Systems Segment by Application
2.4.1 Hospitals
2.4.2 Physical Examination Center
2.4.3 Physician Groups
2.4.4 Others
2.5 Pulmonary Function Testing Systems Sales by Application
2.5.1 Global Pulmonary Function Testing Systems Sale Market Share by Application (2020-2025)
2.5.2 Global Pulmonary Function Testing Systems Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pulmonary Function Testing Systems Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pulmonary Function Testing Systems Breakdown Data by Company
3.1.1 Global Pulmonary Function Testing Systems Annual Sales by Company (2020-2025)
3.1.2 Global Pulmonary Function Testing Systems Sales Market Share by Company (2020-2025)
3.2 Global Pulmonary Function Testing Systems Annual Revenue by Company (2020-2025)
3.2.1 Global Pulmonary Function Testing Systems Revenue by Company (2020-2025)
3.2.2 Global Pulmonary Function Testing Systems Revenue Market Share by Company (2020-2025)
3.3 Global Pulmonary Function Testing Systems Sale Price by Company
3.4 Key Manufacturers Pulmonary Function Testing Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Function Testing Systems Product Location Distribution
3.4.2 Players Pulmonary Function Testing Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pulmonary Function Testing Systems by Geographic Region
4.1 World Historic Pulmonary Function Testing Systems Market Size by Geographic Region (2020-2025)
4.1.1 Global Pulmonary Function Testing Systems Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pulmonary Function Testing Systems Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pulmonary Function Testing Systems Market Size by Country/Region (2020-2025)
4.2.1 Global Pulmonary Function Testing Systems Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pulmonary Function Testing Systems Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pulmonary Function Testing Systems Sales Growth
4.4 APAC Pulmonary Function Testing Systems Sales Growth
4.5 Europe Pulmonary Function Testing Systems Sales Growth
4.6 Middle East & Africa Pulmonary Function Testing Systems Sales Growth
5 Americas
5.1 Americas Pulmonary Function Testing Systems Sales by Country
5.1.1 Americas Pulmonary Function Testing Systems Sales by Country (2020-2025)
5.1.2 Americas Pulmonary Function Testing Systems Revenue by Country (2020-2025)
5.2 Americas Pulmonary Function Testing Systems Sales by Type (2020-2025)
5.3 Americas Pulmonary Function Testing Systems Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Function Testing Systems Sales by Region
6.1.1 APAC Pulmonary Function Testing Systems Sales by Region (2020-2025)
6.1.2 APAC Pulmonary Function Testing Systems Revenue by Region (2020-2025)
6.2 APAC Pulmonary Function Testing Systems Sales by Type (2020-2025)
6.3 APAC Pulmonary Function Testing Systems Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pulmonary Function Testing Systems by Country
7.1.1 Europe Pulmonary Function Testing Systems Sales by Country (2020-2025)
7.1.2 Europe Pulmonary Function Testing Systems Revenue by Country (2020-2025)
7.2 Europe Pulmonary Function Testing Systems Sales by Type (2020-2025)
7.3 Europe Pulmonary Function Testing Systems Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pulmonary Function Testing Systems by Country
8.1.1 Middle East & Africa Pulmonary Function Testing Systems Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pulmonary Function Testing Systems Revenue by Country (2020-2025)
8.2 Middle East & Africa Pulmonary Function Testing Systems Sales by Type (2020-2025)
8.3 Middle East & Africa Pulmonary Function Testing Systems Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pulmonary Function Testing Systems
10.3 Manufacturing Process Analysis of Pulmonary Function Testing Systems
10.4 Industry Chain Structure of Pulmonary Function Testing Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pulmonary Function Testing Systems Distributors
11.3 Pulmonary Function Testing Systems Customer
12 World Forecast Review for Pulmonary Function Testing Systems by Geographic Region
12.1 Global Pulmonary Function Testing Systems Market Size Forecast by Region
12.1.1 Global Pulmonary Function Testing Systems Forecast by Region (2026-2031)
12.1.2 Global Pulmonary Function Testing Systems Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pulmonary Function Testing Systems Forecast by Type (2026-2031)
12.7 Global Pulmonary Function Testing Systems Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 CareFusion(BD)
13.1.1 CareFusion(BD) Company Information
13.1.2 CareFusion(BD) Pulmonary Function Testing Systems Product Portfolios and Specifications
13.1.3 CareFusion(BD) Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 CareFusion(BD) Main Business Overview
13.1.5 CareFusion(BD) Latest Developments
13.2 Schiller
13.2.1 Schiller Company Information
13.2.2 Schiller Pulmonary Function Testing Systems Product Portfolios and Specifications
13.2.3 Schiller Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Schiller Main Business Overview
13.2.5 Schiller Latest Developments
13.3 CHEST
13.3.1 CHEST Company Information
13.3.2 CHEST Pulmonary Function Testing Systems Product Portfolios and Specifications
13.3.3 CHEST Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 CHEST Main Business Overview
13.3.5 CHEST Latest Developments
13.4 COSMED
13.4.1 COSMED Company Information
13.4.2 COSMED Pulmonary Function Testing Systems Product Portfolios and Specifications
13.4.3 COSMED Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 COSMED Main Business Overview
13.4.5 COSMED Latest Developments
13.5 nSpire Health
13.5.1 nSpire Health Company Information
13.5.2 nSpire Health Pulmonary Function Testing Systems Product Portfolios and Specifications
13.5.3 nSpire Health Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 nSpire Health Main Business Overview
13.5.5 nSpire Health Latest Developments
13.6 NDD
13.6.1 NDD Company Information
13.6.2 NDD Pulmonary Function Testing Systems Product Portfolios and Specifications
13.6.3 NDD Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 NDD Main Business Overview
13.6.5 NDD Latest Developments
13.7 MGC Diagnostics
13.7.1 MGC Diagnostics Company Information
13.7.2 MGC Diagnostics Pulmonary Function Testing Systems Product Portfolios and Specifications
13.7.3 MGC Diagnostics Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 MGC Diagnostics Main Business Overview
13.7.5 MGC Diagnostics Latest Developments
13.8 Minato
13.8.1 Minato Company Information
13.8.2 Minato Pulmonary Function Testing Systems Product Portfolios and Specifications
13.8.3 Minato Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Minato Main Business Overview
13.8.5 Minato Latest Developments
13.9 Ganshorn
13.9.1 Ganshorn Company Information
13.9.2 Ganshorn Pulmonary Function Testing Systems Product Portfolios and Specifications
13.9.3 Ganshorn Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Ganshorn Main Business Overview
13.9.5 Ganshorn Latest Developments
13.10 AESRI
13.10.1 AESRI Company Information
13.10.2 AESRI Pulmonary Function Testing Systems Product Portfolios and Specifications
13.10.3 AESRI Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 AESRI Main Business Overview
13.10.5 AESRI Latest Developments
13.11 Morgan Scientific
13.11.1 Morgan Scientific Company Information
13.11.2 Morgan Scientific Pulmonary Function Testing Systems Product Portfolios and Specifications
13.11.3 Morgan Scientific Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Morgan Scientific Main Business Overview
13.11.5 Morgan Scientific Latest Developments
13.12 M&B
13.12.1 M&B Company Information
13.12.2 M&B Pulmonary Function Testing Systems Product Portfolios and Specifications
13.12.3 M&B Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 M&B Main Business Overview
13.12.5 M&B Latest Developments
13.13 Sikeda
13.13.1 Sikeda Company Information
13.13.2 Sikeda Pulmonary Function Testing Systems Product Portfolios and Specifications
13.13.3 Sikeda Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Sikeda Main Business Overview
13.13.5 Sikeda Latest Developments
13.14 RSDQ
13.14.1 RSDQ Company Information
13.14.2 RSDQ Pulmonary Function Testing Systems Product Portfolios and Specifications
13.14.3 RSDQ Pulmonary Function Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 RSDQ Main Business Overview
13.14.5 RSDQ Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂